KarenElizabethHoffmanMD

Radiation Oncology • Houston, TX

Physician

Join to view full profile

Dr. Hoffman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hoffman's full profile

Already have an account?

Office
1515 Holcombe Blvd Unit 1202
M.D. Anderson Cancer Center
Houston, TX 77030
Phone+1 713-563-8495

Education & Training

Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 2005 - 2009
Georgetown University HospitalInternship, Transitional Year, 2004 - 2005
Duke University School of MedicineClass of 2004

Certifications & Licensure

FL State Medical License 2021 - Present
TX State Medical License 2009 - 2026
OK State Medical License 2020 - 2021
MA State Medical License 2005 - 2010
VA State Medical License 2004 - 2005
American Board of Radiology Radiation Oncology

Clinical Trials

Abiraterone, Radiotherapy and Short-Term Androgen Deprivation in Unfavorable Localized Prostate Cancer Start of enrollment: 2014 Jan 17
Completed
Phase 2
Hypofractionated vs. Conventional Regional Nodal Radiation Therapy for Patients With Invasive Breast Cancer Start of enrollment: 2017 Feb 23
Recruiting
Phase 2
Roles: Contact, Principal Investigator
Pragmatic Randomized Trial of Proton vs. Photon Therapy for Patients With Non-Metastatic Breast Cancer: A Radiotherapy Comparative Effectiveness (RADCOMP) Consortium Trial Start of enrollment: 2016 Feb 01
Active, not recruiting
Not Applicable
Roles: Contact
PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer. Start of enrollment: 2024 Aug 31
Not yet recruiting
Phase 3
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

2 citations
Knowledge-based planning for fully automated radiation therapy treatment planning of 10 different cancer sites.
Christine V Chung, Meena S Khan, Adenike Olanrewaju, Mary Pham, Quyen T Nguyen
Radiotherapy and Oncology. 2025-01-01
Patient-reported functional outcomes and treatment-related regret in Hispanic and Spanish-speaking men following prostate cancer treatment.
Andrea A Lopez, Bashir Al Hussein Al Awamlh, Li-Ching Huang, Zhiguo Zhao, Tatsuki Koyama
Urologic Oncology. 2024-12-16
Financial toxicity in breast cancer patients receiving regional nodal irradiation: Variation by cancer subtype.
Grace L Smith, Benjamin D Smith, Chi-Fang Wu, Simona F Shaitelman, Mariana Chavez-MacGregor
Breast. 2024-12-01

Journal Articles

Association of Transforming Growth Factor Β Polymorphism C−509T with Radiation-Induced Fibrosis Among Patients with Early-Stage Breast CancerA Secondary Analysis of a ...
Karen E Hoffman, Elizabeth S Bloom, Pamela J Schlembach, Thomas A Buchholz, Benjamin D Smith, Wendy A Woodward, Welela Tereffe, Simona F Shaitelman, Michael C Stauder, JAMA
The Implications of Ageing and Life Expectancy in Prostate Cancer Treatment
John W Davis, Spyridon Basourakos, Jeri Kim, Karen E Hoffman, Nature

Lectures

Fee for Service and Physician Facility Ownership
ASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019

Press Mentions

$No Improvement in Lymphedema with Hypofractionated Nodal RT for Breast Cancer$
No Improvement in Lymphedema with Hypofractionated Nodal RT for Breast CancerOctober 1st, 2024
MD Anderson Research Highlights Special Edition: ASTRO 2024September 27th, 2024
Patients Still in Quandary Regarding Treatment for Localized Prostate CancerFebruary 8th, 2020
Join now to see all

Professional Memberships

American Society of Clinical Oncology - ASCO
Member